
AVP, Oncology, Communications
Merck
Summary
The Associate Vice President, Oncology, Communications is responsible for leading the global, end-to-end communications strategy for the company's oncology portfolio, including in-line products, new indications, pipeline assets and emerging platforms. This senior leader will translate oncology business, product and scientific strategies into compelling communications that strengthen the company's leadership in oncology, support portfolio growth and advance the needs of patients.
Job description
Scope of Work and Core Responsibilities
- Serve as the senior communications advisor to Oncology leadership, contributing communications expertise to business, portfolio, product and reputational decisions.
- Develop and execute an integrated global communications strategy for the oncology portfolio that aligns with business priorities, product strategies, clinical development plans and the broader company narrative.
- Translate oncology product strategy into differentiated communications strategies and narratives that articulate clinical value, unmet need, patient impact, competitive positioning and the role of each asset within the broader portfolio.
- Lead communications planning across the full product lifecycle, including early pipeline milestones, pivotal data, regulatory submissions and decisions, medical congresses, launches, label expansions, new indications, lifecycle management and loss-of-exclusivity considerations.
- Partner closely with Global and U.S. Commercial, Research and Development, Medical Affairs, Market Access, Outcomes Research, Regulatory, Legal, Investor Relations, Public Policy, Patient Engagement and regional and market communications teams.
- Build integrated communications plans for priority oncology assets and tumor areas, ensuring consistent positioning while addressing market-specific business needs, stakeholder expectations and regulatory requirements.
- Direct communications for major scientific and medical milestones, including data announcements and presentations at priority medical meetings.
- Provide strategic communications counsel for oncology product launches and indication expansions, including disease-awareness strategies, launch narratives, executive engagement, media strategy, stakeholder materials and internal readiness.
- Strengthen the company's oncology reputation through enterprise storytelling, thought leadership and integrated campaigns.
- Anticipate and manage product, clinical, regulatory and reputational issues; lead scenario planning, rapid-response communications and executive counsel.
- Build and maintain relationships with influential external stakeholders, including healthcare and trade media, oncology experts, patient advocacy organizations, professional societies and other relevant stakeholders.
- Oversee communications related to oncology business development, licensing, acquisitions, alliances and partnerships.
- Establish effective governance, operating rhythms and decision rights across global, regional and market communications teams.
- Lead, coach and develop a high-performing team of communications professionals and agency partners.
- Manage the oncology communications budget and agency roster.
- Define meaningful measures of success and use insights, analytics and external benchmarking to evaluate impact.
Education
Bachelor's degree required; advanced degree in communications, business, science, public health or a related field preferred.
Required Experience and Skills
- Minimum of 15 years of progressive communications experience, including significant leadership experience in the pharmaceutical, biotechnology or healthcare industry.
- Extensive oncology communications experience, with a strong understanding of the oncology market, clinical development, regulatory environment, scientific exchange and evolving standards of care.
- Demonstrated experience developing and executing product strategy communications for oncology assets across multiple lifecycle stages.
- Proven leadership of communications for major product launches, indication expansions, clinical data milestones, regulatory decisions and priority medical congresses.
- Strong ability to translate complex scientific, clinical and commercial information into clear, credible and compelling communications for varied audiences.
- Deep understanding of the relationships among product strategy, portfolio positioning, market access, medical strategy, patient needs, the competitive landscape and corporate reputation.
- Demonstrated success partnering with senior executives and influencing decisions in a highly matrixed, global organization.
- Strong issues and crisis management experience.
- Established ability to build relationships with media, external experts, patient advocacy organizations and other influential stakeholders.
- Proven people leadership experience, including leading leaders, developing talent, managing performance and creating an inclusive, accountable and high-performing culture.
- Exceptional written, verbal, presentation and narrative-development skills.
- Strong business acumen, strategic thinking and ability to balance long-term portfolio priorities with immediate execution needs.
- Demonstrated ability to manage multiple high-visibility priorities, budgets and agency partners in a complex and rapidly changing environment.
Requirements
- Bachelor's degree required
- Minimum of 15 years of progressive communications experience
- Significant leadership experience in pharmaceutical, biotechnology or healthcare industry
- Extensive oncology communications experience
- Understanding of oncology market, clinical development, regulatory environment, scientific exchange and standards of care
- Experience developing and executing product strategy communications for oncology assets across lifecycle stages
- Proven leadership of communications for major product launches, indication expansions, clinical data milestones, regulatory decisions and medical congresses
- Ability to translate complex scientific, clinical and commercial information into compelling communications
- Deep understanding of product strategy, portfolio positioning, market access, medical strategy, patient needs, competitive landscape and corporate reputation
- Demonstrated success partnering with senior executives in a highly matrixed, global organization
- Strong issues and crisis management experience
- Ability to build relationships with media, external experts, patient advocacy organizations and stakeholders
- Proven people leadership experience, including leading leaders and developing talent
- Exceptional written, verbal, presentation and narrative-development skills
- Strong business acumen and strategic thinking
- Ability to manage multiple high-visibility priorities, budgets and agency partners
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Retirement Benefits
- Paid Holidays
- Vacation
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
- Hybrid Work
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.